Ankylosing Spondylitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with ankylosing spondylitis (AS) according to a specific set of medical guidelines called the modified 1984 New York criteria
- Your AS is currently active, meaning your symptoms are significant enough to score 4 or higher on a standard symptom questionnaire called the BASDAI
- You have never previously taken any medications from the TNF inhibitor, JAK inhibitor, or IL-17 inhibitor drug families (common examples include adalimumab, tofacitinib, or ixekizumab — confirm with trial site)
- You are considered suitable for treatment with a medication called secukinumab, based on official guidelines from the Ministry of Food and Drug Safety
- You were diagnosed with AS less than 5 years ago
- You are between 18 and 40 years old
- You are willing and able to give written consent to take part in the study
Who may not be able to join:
- You have a physical or mental health condition that would make it difficult to take part in the full study period (approximately 28 weeks)
- You have spinal deformities that were present from birth or caused by an injury
- You are currently taking part in another clinical trial
- You have any medical reasons why taking secukinumab would not be safe for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41613241111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.